JAMA Network Home
Sign In
Research Letter

Access Barriers to Pembrolizumab in Brazil

JAMA Network Open 10.1001/jamanetworkopen.2025.28585

August 22, 2025 at 11:00 AM EDT

Read the full article

This cross-sectional study examines the lawsuits that followed national and international policies for pembrolizumab approval.

Corresponding Author: Pedro Luiz Serrano Uson, Jr, Center for Personalized Medicine, Hospital Israelita Albert Einstein, Avenida Albert Einstein, 627, Sao Paulo 05652000, Brazil (pedro.serrano@einstein.br).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.28585?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082225

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks